Cargando…
The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system
The compound BAY 11-7082 inhibits IκBα [inhibitor of NF-κB (nuclear factor κB)α] phosphorylation in cells and has been used to implicate the canonical IKKs (IκB kinases) and NF-κB in >350 publications. In the present study we report that BAY 11-7082 does not inhibit the IKKs, but suppresses their...
Autores principales: | Strickson, Sam, Campbell, David G., Emmerich, Christoph H., Knebel, Axel, Plater, Lorna, Ritorto, Maria Stella, Shpiro, Natalia, Cohen, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685219/ https://www.ncbi.nlm.nih.gov/pubmed/23441730 http://dx.doi.org/10.1042/BJ20121651 |
Ejemplares similares
-
The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways
por: Cohen, Philip, et al.
Publicado: (2017) -
In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
por: Debnath, Anjan, et al.
Publicado: (2018) -
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
por: Pustchi, Sadaf E., et al.
Publicado: (2020) -
SPOP promotes ubiquitination and degradation of MyD88 to suppress the innate immune response
por: Li, Qinghe, et al.
Publicado: (2020) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021)